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Conductive hearing loss causes a progressive decline in cochlear activity that may result
in functional and structural modifications in auditory neurons. However, whether these
activity-dependent changes are accompanied by a glial response involving microglia,
astrocytes, or both has not yet been fully elucidated. Accordingly, the present study was
designed to determine the involvement of glial related mechanisms in the anteroventral
cochlear nucleus (AVCN) of adult rats at 1, 4, 7, and 15 d after removing middle ear ossicles.
Quantitative immunohistochemistry analyses at light microscopy with specific markers of
microglia or astroglia along with immunocytochemistry at the electron microscopy level
were used. Also, in order to test whether trophic support by neurotrophins is modulated
in glial cells by auditory activity, the expression and distribution of neurotrophin-3 (NT-3)
and its colocalization with microglial or astroglial markers was investigated. Diminished
cochlear activity after middle ear ossicle removal leads to a significant ipsilateral increase
in the mean gray levels and stained area of microglial cells but not astrocytes in the AVCN
at 1 and 4 d post-lesion as compared to the contralateral side and control animals. These
results suggest that microglial cells but not astrocytes may act as dynamic modulators
of synaptic transmission in the cochlear nucleus immediately following unilateral hearing
loss. On the other hand, NT-3 immunostaining was localized mainly in neuronal cell bodies
and axons and was upregulated at 1, 4 and 7 d post-lesion. Very few glial cells expressed
this neurotrophin in both control and experimental rats, suggesting that NT-3 is primarily
activated in neurons and not as much in glia after limiting auditory activity in the AVCN by
conductive hearing loss.
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INTRODUCTION
Conductive hearing loss is a condition that results in diminished
cochlear nerve synaptic activity due to an inefficient sound trans-
mission from themiddle to the inner ear (Conlee and Parks, 1981;
Tucci and Rubel, 1985). Physiological studies in adult patients
and children who suffer from unilateral conductive ear disease
have demonstrated that this hearing impairment results in func-
tional anomalies in brainstem auditory evoked responses (ABRs)
(Fria and Sabo, 1980; Ferguson et al., 1998). In both adult and
juvenile populations, ABR recordings showed significant delays
in wave V and in the III-IV interwave intervals. This observa-
tion has led to the suggestion that conductive hearing loss is
associated with alterations at the central level that might have
a significant impact on auditory processing. In an attempt to
improve the diagnosis and treatment of these patients, animal
models of conductive hearing loss have been developed to eluci-
date the morphological and functional anomalies associated with
these pathological responses. In this regard, a series of studies
have demonstrated that unilateral restriction of peripheral inputs
to central auditory nuclei leads to decreased activity in auditory
neurons of the affected side (Tucci et al., 1999, 2001, 2002; Hutson
et al., 2007), strengthening of the ipsilateral projection from the
cochlear nucleus to inferior colliculus (Moore et al., 1989), alter-
ations in neurotransmitters release and uptake (Potashner et al.,
1997; Suneja et al., 1998), redistribution of AMPA and glycine
receptor subunits (Whiting et al., 2009), and modifications in
the synthesis and composition of glutamate and glycine receptors
(Wang et al., 2011).
Imbalance of neurotransmission after bilateral deprivation
of cochlear activity results in long-term interactions between
microglial cells and deafferented cochlear nucleus neurons
(Campos Torres et al., 1999; Fuentes-Santamaria et al., 2012).
In response to modifications in chemical and electrical sig-
nals from damaged neurons, microglia rapidly changes to an
active phenotype promoting the synthesis and release of cel-
lular mediators, as an attempt to restore synaptic homeosta-
sis and function (Bruce-Keller, 1999; Cullheim and Thams,
2007; Hanisch and Kettenmann, 2007). Growth factors, includ-
ing neurotrophins, and cytokines are activity-dependent signal-
ing molecules involved in the regulation of synaptic activity in
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Table 1 | Antibodies used for Immunohistochemistry.
Primary Immunogen Host Code/clone Dilution Manufacturer Tissue
Antibody processing
Iba1 C-terminus of Iba1′
(N′-PTGPPAKKAISELP-C′)
Rabbit 019–19741, Lot #CDQ5232 1:2000 Wako Pure Chemical Industries,
Neuss, Germany
LM, CM, EM
CD11b Rat peritoneal macrophages Mouse MCA275G 1:100 Serotec, Oxford, UK CM
GFAP Cow spinal cord GFAP Rabbit Z0334 1:2000 Dako, Glostrup, Denmark LM, EM
GFAP Porcine spinal cord GFAP Mouse MAB360 1:2000 Millipore, Billerica, MA, USA CM
NeuN Purified cell nuclei from mouse
brain
Mouse MAB337, Lot # LV1825845 1:200 Millipore, Billerica, MA, USA CM
NT-3 Amino-terminal of mouse NT-3
(H-YAEHKSHRGEY-NH2)
Rabbit AB1532SP 1:100 Millipore, Billerica, MA, USA LM,CM
LM, light microscopy; CM, confocal microscopy; EM, electron microscopy.
FIGURE 1 | Line graphs depicting ABR recordings at 80dB SPL for all
frequencies tested in control (A) and experimental animals following
UCHL (B–F). In control animals (A) and in the contralateral side (B), ABR
recordings show a normal wave pattern, which was characterized by
positive peaks generated following the stimulus onset (dashed lines).
However, post-lesion (pl) ABRs at all timepoints, showed reduction of the
responses following stimulus onset (dashed lines) at all frequencies
evaluated (C–F).
the healthy and injured brain (Guthrie et al., 1995; Watt and
Hobbs, 2000; Hanisch, 2002; Parish et al., 2002). Studies in dif-
ferent lesion models such as ischemia and traumatic brain injury
have shown increased production of insulin-like growth fac-
tor 1 (IGF-1) and interleukin-1β (IL-1β) by glial cells (Touzani
et al., 1999; Rothwell and Luheshi, 2000; Hwang et al., 2004;
Madathil et al., 2010). Particularly in the auditory system,
FIGURE 2 | Line graphs illustrating the effects of UCHL over the
auditory thresholds at all frequencies tested. (A) There was a
significant threshold elevation in the ipsilateral side at all timepoints after
the UCHL in comparison with control animals and the contralateral side of
deprived rats. (B) The threshold shift was of 30–40 dB SPL in comparison
to the contralateral side and unoperated rats. The error bars indicate the
standard errors of the mean.
upregulation of IGF-1 and IL-1β levels occurs in neurons but
not in either astrocytes or microglia within the ventral cochlear
nucleus (AVCN) of adult rats at 1, 7, and 15 d after cochlear abla-
tion (Fuentes-Santamaria et al., 2013). These findings support the
idea that additional synthesis of IGF-1 and IL-1β by glial cells is
not essential to re-establish damaged auditory synaptic
connections and that other molecular mediators might be
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FIGURE 3 | Images depicting Iba1 immunostaining in the AVCN in
control and experimental animals. In the ipsilateral side, Iba1
immunostaining increased at 1d post-lesion (arrows in C) and peaked
around 4d (arrows in D) in comparison with the contralateral side and
unoperated animals (arrows in A,B). Iba1 levels remained elevated at 7d
(arrows in E) and decreased at 15d (arrows in F) post-lesion. The
morphological features of these cells are shown in G–K. Particularly at 7d
post-lesion, activated microglial cells assumed very diverse phenotypes
(compare asterisk and arrows in E). The inset in A indicates the location
of the AVCN, and the square box indicates the approximate locations of
the fields represented in A–F. Scale bar = 250μm in A; 50μm in
F; 10μm in K.
involved in this process. One possible candidate is neurotrophin-
3 (NT-3), a neurotrophic factor expressed in the adult and
postnatal auditory system (Hafidi, 1999; Tierney et al., 2001).
Apart from its role as a survival factor that, when injected into
the cochlea, increases the survival of spiral ganglion neurons
after deafness (Wise et al., 2011), NT-3 also participates in the
reestablishment of lost synaptic connections. Supporting this
concept, increases in NT-3 levels have been found in adult guinea
pigs at 7d following unilateral cochlear removal, a time point
at which degeneration and synaptogenesis processes take place
in the cochlear nucleus (Suneja et al., 2005). It is not known,
however, whether NT-3 is dynamically expressed in glial cells
after auditory lesions like unilateral conductive hearing loss
(UCHL).
In addition to these changes, investigations in several species
have provided insights into the role that reactive astrocytes might
play in restoring synaptic homeostasis after sensorineural hear-
ing loss (Lurie and Rubel, 1994; De Waele et al., 1996; Insausti
et al., 1999; Lurie andDurham, 2000; Campos-Torres et al., 2005).
Particularly in the cochlear nucleus, recent findings indicate that
after cochlear ablation astrocytic activation is delayed (24 h)
and less persistent (<30d) relative to microglial responses, which
appear earlier (16 h) and last longer (>90d) (Fuentes-Santamaria
et al., 2012). These observations support the idea that although
these non-neuronal elements have different temporal patterns
of activation, they both are implicated in reestablishing synaptic
function following deafness. In the present study, we interrupted
the conduction of sound from the middle ear to the inner ear to
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FIGURE 4 | Bar graphs showing the mean cross-sectional areas of Iba1
immunostained cells (A,B), the mean gray levels of the immunostaining
(C,D) and the immunostained areas (E,F) in the AVCN of control and
deprived animals. These three indexes were significantly increased at 1, 4,
and 7 d but not at 15d after ossicle removal in comparison with the
contralateral side and unoperated animals. The percentages of variation for
each quantitative index are shown in B,D,F. The error bars indicate the
standard errors of the mean.
assess whether or not glial cells express NT-3 and contribute to
the recovery of synaptic deficits associated with UCHL.
MATERIALS AND METHODS
ANIMALS
All animal protocols were approved by the Institutional Animal
Care and Use Committee at the University of Castilla-La Mancha
(Permit Number: PR-2013-02-03). These protocols were in accor-
dance with the guidelines of the European Communities Council
(Directive 2010/63/EU) and current national legislation (R.D.
53/2013; Law 32/2007) for the care and use of research animals.
For light and confocal microscopy, 16 experimental and 4 age-
matched unmanipulated control rats were used. An additional
group of 12 experimental and 3 age-matched unmanipulated
control rats was used for electron microscopy. Two month-old
female adult rats were used for all experiments. Following the
surgical procedure, the experimental animals survived for 1, 4,
7, or 15 d.
AUDITORY BRAINSTEM RESPONSES (ABR)
Animals were anesthetized with isofluorane (4% for induc-
tion, 1.5–2% for maintenance with a 1 L/min O2 flow rate)
and placed in a sound-attenuating electrically shielded booth
(Eymasa/Incotron S.L., Barcelona, Spain) which was located
inside a sound-attenuating room. Subdermal needle electrodes
(Rochester Electro-Medical, Tampa, FL, USA) were placed
at the vertex (positive) and under the right (negative) and
left (ground) ears. The stimulation and recording were per-
formed with a Tucker-Davis (TDT) BioSig System III (Tucker-
Davis Technologies, Alachua, FL, USA). As previously reported
(Alvarado et al., 2012, 2014), the ABR recordings were performed
the day before the surgical procedure and at the end of
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Table 2 | Iba1 immunostaining in the AVCN in control and
experimental animals.
CSA (µm2) MGL ISA (µm2)
S
ur
vi
va
lt
im
e
Control (1) 36.6 ± 0.9 101.2 ± 1.6 2021.9 ± 83.3
Contra (2) 38.1 ± 1.4 104.1 ± 1.3 1962.9 ± 84.4
1d (3) 54.7 ± 1.4 130.9 ± 1.1 2692.3 ± 99.3
4d (4) 58.4 ± 1.5 151.6 ± 2.2 3373.4 ± 79.2
7d (5) 49.6 ± 0.9 132.6 ± 1.2 2916.1 ± 51.8
15d (6) 39.4 ± 1.3 112.6 ± 1.9 2156.4 ± 67.6
ANOVA F(5,954) = 54.8 F(5,174) = 141.6 F(5,174) = 51.42
p < 0.001 p < 0.001 p < 0.001
Significance levels
S
ta
tis
tic
al
C
om
pa
ris
on
1 vs. 2 NS NS NS
1 vs. 3 *** *** ***
1 vs. 4 *** *** ***
1 vs. 5 *** *** ***
1 vs. 6 NS ** NS
2 vs. 3 *** *** ***
2 vs. 4 *** *** ***
2 vs. 5 *** *** ***
2 vs. 6 NS * NS
3 vs. 4 NS *** ***
3 vs. 5 NS NS NS
3 vs. 6 *** *** **
4 vs. 5 *** *** ***
4 vs. 6 *** *** ***
4 vs. 6 *** *** ***
Values are means ± standard errors. CSA, Cross-sectional area of Iba1 immunos-
tained cells; MGL, Mean gray level of Iba1 immunostaining; ISA, Immunostained
area of Iba1. *p < 0.05; **p < 0.01; ***p < 0.001; NS, No significant.
each survival time. The stimuli were digitally generated using
the SigGenRP software (Tucker-Davis Technologies) and the
RX6 Piranha Multifunction Processor hardware (Tucker-Davis
Technologies) and consisted of 5ms rise/fall time tones, with
no plateau and a cos2 envelope, delivered at 20/secat differ-
ent frequencies across 7 octaves, from 0.5 to 32 kHz. They
were delivered monaurally (right ear) using an EDC1 electro-
static speaker driver (Tucker-Davis Technologies) and the EC-
1 electrostatic speaker (Tucker-Davis Technologies) which was
placed into the external auditory meatus of the rat. Prior to
the experiments, stimuli were calibrated using the SigCal soft-
ware (Tucker-Davis Technologies) and the ER-10B+ low noise
microphone system (Etymotic Research Inc, Elk, Groove, IL,
USA). The evoked potentials were filtered (0.3–3.0 kHz), aver-
aged (500 waveforms) and stored for later analyses on a com-
puter. Auditory thresholds, for each of the frequencies evaluated,
were determined comparing the evoked activity, recorded in
5 dB steps descending from a maximum stimulus intensity of
80 dB SPL, with the background activity measured before the
stimulus onset. Auditory thresholds were defined as the stim-
ulus intensity that evoked waves with a peak-to-peak voltage
greater than 2 standard deviations above the background activity
(Cediel et al., 2006; Garcia-Pino et al., 2010; Alvarado et al., 2012,
2014).
SURGICAL PROCEDURE FOR UNILATERAL CONDUCTIVE HEARING LOSS
All surgical procedures were performed under aseptic conditions
and unilaterally on the right ear. Rats were anesthetized with
isofluorane as indicated above. Once the skin behind the ears was
shaved, a retroauricular incision was made in order to identify
the external auditory canal, which was followed to the tym-
panic membrane. Using fine forceps, the tympanic membrane
was punctured and the malleus and incus were removed. During
the surgical procedure a heating pad was used to maintain normal
body temperature and recovery from anesthesia. Once awake, ani-
mals were returned to their cages and maintained with free access
to food and water for the survival period.
PRIMARY ANTIBODIES
The antibodies used in this study are listed in Table 1. Glial
and neuronal antibodies included (1) mouse anti-glial fibrillary
acidic protein (GFAP); (2) rabbit anti-glial fibrillary acidic pro-
tein (GFAP); (3) ionized calcium binding adaptor molecule 1
(Iba1); (4) mouse anti-CD11b; (5) mouse anti-neuronal nuclei
(NeuN) and (6) rabbit anti-neurotrophin-3 (NT-3).
IMMUNOPEROXIDASE STAINING PROCEDURE
After the appropriate post-operative survival time, control and
experimental rats were anesthetized with an intraperitoneal
injection of ketamine (100mg/Kg) and xylazine (5mg/Kg) and
perfused transcardially with 0.9% saline wash followed by a
fixative solution of 4% paraformadehyde in 0.1M phosphate
buffer (PB, pH 7.3). The brains were removed from the cra-
nium, and crioprotected for 48 h. Frozen sections 40μm thick
were cut on a sliding microtome in a coronal plane. After
blocking for 1 h in a solution containing 10% normal goat
serum (NGS) diluted in Tris-buffered saline (TBS, pH 7.4)
with 0.2% Triton X-100 (TBS-Tx 0.2%), sections were subse-
quently incubated overnight at 4◦C in the same buffer solution
with polyclonal primary antibodies for either Iba1 or GFAP
or NT-3 (Table 1). The next day, sections were washed in a
TBS-Tx 0.2% solution and incubated for 2 h at room temper-
ature (RT) in biotinylated goat anti-rabbit secondary antibody
(1:200, Vector Laboratories, Burlingame, CA, USA). Then, after
several rinses in TBS-Tx 0.2%, sections were incubated in an
avidin-biotinylated peroxidase complex (ABC) and rinsed in TBS.
Sections were then exposed to 3–3′ dimanobenzidine (DAB)
as the chromogenic peroxidase substrate. Care was taken to
ensure that incubation times in DAB were identical across con-
trol and experimental cases. Finally, the sections were washed
thoroughly, mounted on gelatin-coated slides, air-dried, dehy-
drated in progressive ethanol solutions, cleared in xylene, and
coverslipped with Cytoseal® (Stephens Scientific, Wayne, NJ,
USA). Three sets of control experiments were performed to test
the specificity of immunohistochemistry detection system: (1)
omission of the primary antibody by replacement with TBS-
BSA; (2) omission of secondary antibodies; and (3) omission
of ABC reagent. No immunostaining was detected under these
conditions.
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FIGURE 5 | Confocal images showing appositions between microglial
cells and neurons in the ipsilateral AVCN in control and deprived rats. In
control rats, microglial cells with round or fusiform cell bodies and ramified
processes were in close proximity to cochlear nucleus neurons (arrows and
asterisks in A–C). The frequency of these appositions was particularly
increased at 1 and 4 d after the lesion, when enlargedmicroglial cell bodieswith
short processes were frequently observed opposing the soma and dendrites
of cochlear nucleus neurons in the affected side (arrows and asterisks in D–F).
At later survival times after ossicle removal, the occurrence of these cellular
contacts decreased (arrows and asterisks in G–L). Scale bar = 25μm in L.
DOUBLE IMMUNOFLUORESCENCE LABELING
Sections were rinsed four times in TBS-Tx 0.2% and blocked
for 1 h in the same buffer solution containing 10% NGS. Then,
sections were incubated incubated overnight with one of the fol-
lowing mixtures of primary antibodies: (1) NeuN and Iba1; (2)
NeuN and GFAP; (3) NT-3 and CD11b; and (4) NT-3 and GFAP
primary antibodies. Following four 15min rinses in TBS-Tx
(0.2%), sections were incubated in the corresponding cocktail
of fluorescently labeled secondary antibodies for 2 h at room
temperature (1:200, anti-mouse antibodies conjugated to Alexa
594 (A-11005) and anti-rabbit antibodies conjugated to Alexa
488 (A-11008; Molecular Probes, Eugene, OR, USA) and after
several rinses in TBS, they were mounted, counterstained with
DAPI, coverslipped, and maintained overnight at 4◦C. Sections
were examined with a laser scanning confocal microscope (LSM
710; Zeiss, Germany) with excitation laser lines at 405, 488, and
594 nm, using the ZEN 2009 Light Edition software. Maximum
intensity projections of a z-stack were generated. For each dye,
optical sections every 2.5μm through the thickness of the tissue
were captured with a 63X Plan Apo oil-immersion objective (1.4
NA), at fixed camera gain, pinhole size, and laser intensity. Then,
images were merged and saved as TIFF files.
ELECTRON MICROSCOPY IMMUNOCYTOCHEMISTRY
Animals were anesthetized as described above and perfused
transcardially with 0.9% saline wash followed by a fixative
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FIGURE 6 | Electron microscopy images showing the ultrastructural
features of Iba1 immunostained cells in the ipsilateral AVCN in
comparison to the contralateral side and control animals. In the control
condition (A) and in the contralateral side (B) to the lesion, microglial cells
have a nucleus with dense heterochromatin, a cytoplasm with numerous
organelles and inclusion bodies. Note that multiple labeled processes (P1–P4)
of different sizes and shapes are scattered in the neuropil. Between 1 and 7 d
following unilateral ossicle removal, these cells have a larger cytoplasm and
thicker processes rich in vacuoles and multi-vesicular bodies (asterisks) that
were seen contacting nearby synaptic elements (C,D). A × 1–A × 2, axons;
D, dendrite; N, nucleus; P1–P4, processes; T, terminal. Scale bar = 2μm in A;
1μm in B,D; 0.5μm in C.
perfusion of 4% paraformadehyde and 0.5% glutaraldehyde in
0.1M PB, pH 7.3. After fixation, the brains were removed,
and sectioned at 40μm on a vibratome in the coronal plane.
After several washes in PBS, sections were pre-incubated for
1 h in 10% NGS and then incubated overnight at 4◦C with
either Iba1 or GFAP polyclonal antibodies diluted in PBS. The
following day, after several rinses in PBS, sections were incu-
bated in a dilution of anti-rabbit secondary antibody (1:200)
for 2 h at RT and after several rinses they were incubated in
ABC for 1 h. Peroxidase activity was visualized with a nickel-
intensified DAB reaction to produce a black reaction product.
Sections containing the cochlear nucleus were post-fixed with
osmium tetraoxide (1% in 0.1M PB) for 1 h, block-stained with
1% uranyl acetate for 30min, dehydrated in graded series of
ethanol and embedded in Durcupan (Fluka) resin. Thin sections
(∼75 nm) in the silver-gold range were cut on an ultramicrotome
(Reichert Ultracut E, Leica, Austria) and collected on 200-mesh
copper grids. Tissue was observed using a Jeol-1010 electron
microscope.
MEASUREMENTS OF THE CROSS-SECTIONAL AREA OF IBA1
IMMUNOSTAINED CELLS
As glial cells could modify their phenotype in response to
minor changes in their cellular environment, the cross-sectional
area, was used as an indicator of possible changes in the
soma size of glial cells at the different time points after
the UCHL. The cross-sectional area of Iba1 immunostained
cells in both control and experimental animals was mea-
sured using the public domain image analysis software Scion
Image for Windows (Scion, Frederick, MD; v beta 4.0.2).
Using a 60× objective, three fields (25.16 × 103 μm2; dor-
sal, middle and ventral) were sampled randomly in every
fourth section throughout the rostrocaudal extent of the
cochlear nucleus. Only cells with a well-defined cell body,
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FIGURE 7 | Images depicting GFAP immunostaining in the AVCN in
control rats and following unilateral ossicle removal.GFAP immunostaining
in the ipsilateral side did not change at any survival time after the lesion (C–F) in
comparison with the contralateral side (B) and unoperated (A) animals. Bar
graphs show the mean gray levels of GFAP immunostaining (G,H) and the
immunostained areas (I,J). When the two indexes were evaluated in the
ipsilateral cochlear nucleus of unilaterally deprived animals at all the timepoints
studied, there were no differences when compared with the contralateral side
and unoperated animals. The error bars indicate the standard errors of the
mean. The inset in A indicates the location of the AVCN, and the square box
indicates the approximate locations of the fields represented in A–F. Scale bar
= 250μm in A; 25μm in F.
nucleus and nucleolus were measured and included in the
analysis.
ANALYSIS OF THE IMMUNOSTAINING
Immunostained sections from control and experimental animals
were examined with bright field illumination using a Nikon
Eclipse photomicroscope with a 40× objective and images cap-
tured with a DXM 1200C digital camera attached to the micro-
scope. Color images of each field were digitized and the resultant
8-bit image contained a grayscale of pixel intensities that ranged
from 0 (white) to 255 (black). As previously described (Fuentes-
Santamaria et al., 2003, 2005, 2007; Alvarado et al., 2004, 2005,
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Table 3 | GFAP immunostaining in the AVCN in control and
experimental animals.
MGL ISA (µm2)
S
ur
vi
va
lt
im
e
Control (1) 132.5 ± 1.9 2141.2 ± 134.2
Contra (2) 131.3 ± 1.6 2049.3 ± 131.1
1d (3) 134.7 ± 2.0 2095.8 ± 126.6
4d (4) 133.3 ± 1.9 2078.3 ± 135.3
7d (5) 132.5 ± 1.5 2042.5 ± 126.3
15d (6) 131.8 ± 1.7 2191.1 ± 133.9
ANOVA F(5,114) = 0.4 F(5,114) = 0.2
NS NS
Significance levels
S
ta
tis
tic
al
C
om
pa
ris
on
1 vs. 2 NS NS
1 vs. 3 NS NS
1 vs. 4 NS NS
1 vs. 5 NS NS
1 vs. 6 NS NS
2 vs. 3 NS NS
2 vs. 4 NS NS
2 vs. 5 NS NS
2 vs. 6 NS NS
3 vs. 4 NS NS
3 vs. 5 NS NS
3 vs. 6 NS NS
4 vs. 5 NS NS
4 vs. 6 NS NS
5 vs. 6 NS NS
Values are means ± standard errors. MGL, Mean gray level of GFAP immunos-
taining; ISA, Immunostained area of GFAP; NS, No significant.
2007), the densitometric procedure for the evaluation of the
immunostaining was performed by using the public domain
image analysis software Scion Image for Windows. Cochlear
nucleus subdivisions were defined in accordance with previous
terminology (for review, see Cant and Benson, 2003). The analy-
sis of Iba1, GFAP and NT-3 immunostaining was performed in 6
coronal sections, 120μm apart, through the rostrocaudal extent
of the AVCN. In each section, three fields (55.25 × 103 μm2 dor-
sal, middle and ventral) were sampled using a 40× objective. In
order to perform an appropriate comparison of the immunos-
taining among cases, a macro was designed to process and analyze
the captured images (Alvarado et al., 2004). Briefly, images were
normalized by using an algorithm, based on the signal-to noise
ratio that normalizes each pixel, adjusting the grayscales range of
the image. Following normalization, the threshold level was set
as two standard deviations above the mean gray level of the field
and immunostained cells exceeding this threshold were identi-
fied as labeled. Additionally, as both the intensity and area of the
immunostaining could be affected by changes in activity (Caicedo
et al., 1997), the mean gray level of the immunostaining and the
immunostained area were used as indicators of changes in protein
levels (Winsky and Jacobowitz, 1995; Benson et al., 1997).
It has been demonstrated that the intensity of the immunos-
taining is related to antigen concentration (Huang et al., 1996;
Yao and Godfrey, 1997). Therefore, the mean gray level was used
as an indirect measure of intracellular protein levels within cells
after UCHL providing a general estimation of the effect of the uni-
lateral deprivation on the immunostaining of neurons and glia.
Additionally, the immunostained area was used as an indicator of
the area occupied by microglial cells and astrocytes at each sur-
vival time in comparison to control rats. It was calculated as the
summed area of all profiles (cells and processes) labeled above the
threshold in each field.
PREPARATION OF FIGURES AND STATISTICAL ANALYSIS
Photoshop (Adobe v5.5) and Canvas (Deneba v6.0) were used
to adjust size, brightness and contrast of publication images. All
the data were expressed as means ± standard error of the mean.
Comparisons among groups were analyzed statistically using the
one-factor analysis of variance and the Scheffe’s post-hoc analysis
to evaluate the effect of the survival time after unilateral conduc-
tive hearing loss over the immunostaining in the cochlear nucleus.
Statistical significance was set at a level of p < 0.05.
RESULTS
AUDITORY BRAINSTEM RESPONSES (ABR)
To evaluate alterations in auditory function following UCHL,
ABR recordings were performed in rats before (pre-lesion ABR)
and after (post-lesion ABR) unilateral ossicle removal for each of
the time points described in the Materials and Methods Section.
Similar to the control condition, the pre-lesion recordings showed
a distinctive wave pattern characterized by four to five positive
peaks generated after a stimulus (Figure 1A). Meanwhile, the
post-lesion ABR in the ear ipsilateral to the lesion (Figures 1C–F)
showed differences in the wave amplitudes at all the frequencies
tested when compared to the contralateral side (Figure 1B) and
control animals (Figure 1A). Experimental rats had significant
thresholds elevations at all frequencies and time points studied
after UCHL which were indicative of decreased activity in the
ipsilateral auditory nuclei (Figure 2).
MICROGLIAL RESPONSE TO UCHL
In the control condition and in the side contralateral to the
lesion, microglial cells in the AVCN had round or oval cell bod-
ies and long ramified processes (Figures 3A,B,G). A microglial
reaction in the ipsilateral AVCN of experimental animals was first
detectable 1 day after the lesion, at which time glial cells had larger
cell bodies along with thicker and less branched processes than
resting microglia (Figures 3C,H). At 4d post-lesion, microglial
expression was maximal (Figures 3D,I) when compared to that in
the intact side (Figure 3B) and control (Figure 3A) animals. Cells
were larger, darker and occupied a larger area when compared to
those observed at 1d post-lesion. These qualitative observations
were confirmed by significant increases in their cross-sectional
area, mean gray level of Iba1 immunostaining and immunos-
tained area (Figure 4; Table 2). At 7d post-lesion, glial cells dis-
played a remarkable heterogeneity in their morphology. Some
cells had smaller cell bodies and longer processes (arrowheads
in Figures 3E,J) while others had morphologies resembling those
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FIGURE 8 | Confocal and electron microscopy images illustrating
appositions between astrocytes and cochlear nucleus neurons in
control and deprived rats. Note that astrocytic processes were distributed
in the neuropil or closely associated to cochlear nucleus neurons in control
and deprived animals (A–C). The utrastructural characteristics of these cells
in the cochlear nucleus are shown in D,E. These macroglial cells were
contacting with surrounding cellular elements of the neuropil in the control
condition and after ossicle removal (asterisks in D,E). A, axon; As, astrocyte;
T, terminal; D, dendrite. Scale bar = 20μm in C (also applies to A,B); 1μm in
D; 2μm in E.
seen at 1 and 4 d post-lesion (compare asterisk and arrows in
Figure 3E). At this time point, the microglial cross-sectional area
was significantly decreased when compared with the other sur-
vival time points. However, it was increased when compared
with the unmanipulated side and control animals (Figures 3, 4;
Table 2). Glial cells were still darkly immunostained as confirmed
by significant decreases in the mean gray levels when compared
with experimental animals at 4d post-lesion, but no differ-
ences were found when compared with 1d post-lesion animals
(Figure 4; Table 2). At longer survival times (15d post-lesion),
microglial cells adopted the typical ramified structure usually seen
in the normal brain (Figures 3F,K, 4).
Microglial-neuronal appositions in the ipsilateral AVCN were
predominantly observed at 1 and 4 d post-lesion (Figures 5D–F),
when microglia assumed a more amoeboid phenotype (arrows
in Figure 5E) and surrounded injured cochlear neurons (aster-
isks in Figure 5D). These close appositions were less frequently
seen at day 7 (Figures 5G–I) and were almost absent at day 15
(Figures 5J–L) when microglial cells transformed into the rami-
fied phenotype similar to that seen in the contralateral side and
control animals (Figures 5A–C). The utrastructural features of
Iba1 immunostained cells in the cochlear nucleus of control and
experimental rats are shown in Figure 6. Iba1 immunostained
microglial cells were identified by the presence of electron-dense
DAB reaction product within their cell body cytoplasm and pro-
cesses. In the control condition and the side contralateral to
the lesion, microglial cells in the resting ramified state had a
nucleus with dense heterochromatin packed against the nuclear
membrane, a cytoplasm with numerous organelles and inclu-
sion bodies and multiple labeled processes of different sizes and
shapes in the neuropil (Shapiro et al., 2009; Figures 6A,B). In
the ipsilateral AVCN of experimental animals, activated microglia
was characterized by an enlarged cytoplasm and thicker processes
rich in vacuoles and multi-vesicular bodies, which were observed
surrounding neuronal processes and contacting nearby synaptic
elements (Figures 6C,D).
ASTROGLIAL RESPONSE TO UCHL
GFAP immunostaining in unmanipulated animals was observed
mostly as branched astroglial processes heterogeneously dis-
tributed through the AVCN (Figure 7A). Following UCHL, the
morphology and staining features of astrocytes were similar to
those observed in control animals (Figures 7A–F). Quantification
of the mean gray levels and immunostained areas of GFAP
immunostaining in experimental animals indicated that there
were no differences at any survival time when compared to either
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FIGURE 9 | Images depicting NT-3 immunostaining in the AVCN in
control and deprived animals. In the ipisilateral side, the immunostaining
increased at 1, 4, and 7 d post-lesion (arrows in C–E) in comparison with the
contralateral side and unoperated animals (arrows in A,B). Note that NT-3
levels decreased at 15d post-lesion in comparison to the other survival time
points (arrows in F). This upregulation was confirmed by significant increases
in the mean gray level of the immunostaining at the above mentioned
survival times (G,H). The inset in A indicates the location of the AVCN, and
the square box indicates the approximate locations of the fields represented
in A–F. Scale bar = 250μm in A; 50μm in F.
the contralateral side or normal control animals (Figures 7G–J;
Table 3). Similar to the control condition, astrocytic processess
were found in the neuropil or closely associated with cochlear
nucleus cell bodies at all the time points studied (Figures 8A–C).
The utrastructural features of astrocytes in the AVCN of con-
trol and experimental rats are shown in Figures 8D,E. These
macroglial cells contacted surrounding cellular elements in the
neuropil (asterisks in Figures 8D,E)
UPREGULATION OF NT-3 IMMUNOSTAINING FOLLOWING UCHL
In control and experimental animals, NT-3 immunostaining was
localized within the cell cytoplasm and also in the neuropil in the
AVCN (Figure 9). At 1, 4, and 7 d post-lesion (Figures 9C–E),
immunostaining in the ipsilateral side was significantly increased
compared to the contralateral side and to normal control animals
(Figures 9A,B). These observations were corroborated by signif-
icant increases in the mean gray level of the immunostaining at
the above mentioned survival times (Figures 9G,H; Table 4).
To determine whether glial cells expressed NT-3 following
UCHL, double-labeling experiments with neuronal and glial
markers were performed in both control and experimental ani-
mals. Few microglial cells (Figure 10) and astrocytes (Figure 11)
colocalyzed with NT-3, demonstrating that neurons and nerve
terminals are the main sources of NT-3 within the AVCN
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Table 4 | NT3 immunostaining in the AVCN in control and
experimental animals.
MGL
S
ur
vi
va
lt
im
e
Control (1) 104.3 ± 2.9
Contra (2) 102.7 ± 2.3
1d (3) 117.9 ± 1.8
4d (4) 148.6 ± 2.3
7d (5) 126.3 ± 2.8
15d (6) 112.6 ± 2.0
ANOVA F(5,144) = 50.8
p < 0.001
S
ta
tis
tic
al
C
om
pa
ris
on
Significance levels
1 vs. 2 NS
1 vs. 3 **
1 vs. 4 ***
1 vs. 5 ***
1 vs. 6 NS
2 vs. 3 **
2 vs. 4 ***
2 vs. 5 ***
2 vs. 6 NS
3 vs. 4 ***
3 vs. 5 NS
3 vs. 6 NS
4 vs. 5 ***
4 vs. 6 ***
5 vs. 6 **
Values are means ± standard errors. MGL, Mean gray level of NT3 immunos-
taining. *p < 0.05; **p < 0.01; ***p < 0.001; NS, No significant.
(Figures 10, 11). The colocalization of activated microglia with
NT-3 in the ipsilateral side in comparison to the contralateral side
and control animals is shown in Figure 10 (yellow arrowheads).
Note the close spatial appositions between NT-3-containing neu-
rons (asterisks in Figure 10) and microglial cells (white arrows
in Figure 10). Regarding astrocytes, as GFAP immunostaining in
the ipsilateral side was similar at all the time points studied after
the lesion in comparison to the contralateral side and control ani-
mals, a representative example of the colocalization of GFAP and
NT-3 in the ipsilateral AVCN at 7d post-lesion (yellow arrows) is
shown in Figure 11.
DISCUSSION
The present study demonstrates that UCHL, which causes a pro-
gressive decline in cochlear nerve activity, leads initially to an
increase in microglial but not astroglial activation in the AVCN
of adult rats, at least up to 15d after the lesion. At 1 and 4 d
following unilateral ossicle removal, Iba1 immunostained cells
were larger and darker in the ipsilateral AVCN when compared
with those in the contralateral side and control animals. These
observations were confirmed by significant increases in the mean
cross-sectional areas of microglial cells and increases in the mean
gray levels of Iba1 immunostaining. When the expression and
distribution of NT-3 and its colocalization with microglial and
astroglial markers was investigated, we observed that NT-3 levels
peaked by day 4 post-lesion, and that most labeling was concen-
trated in neuronal cell bodies and axons. Only few, scattered glial
cells expressed this neurotrophin in control animals and following
monoaural hearing loss. These findings suggest that microglial
cells contribute to restore impaired synaptic function following
UCHL.
Interrupted conduction of sound waves to the inner ear by
means of unilateral middle ear ossicle removal has been reported
to modify the activity of auditory neurons (Woolf et al., 1983;
Tucci et al., 1999, 2001, 2002). In this regard, UCHL in ger-
bils results in either increases or decreases in 2-deoxyglucose
(2-DG) uptake in the ipsilateral cochlear nucleus depending on
whether the animals are maintained in silence following the
2-DG injection (Woolf et al., 1983) or exposed to sound (Tucci
et al., 2001). Also, cytochrome oxidase activity has been shown
to decrease in the ipsilateral cochlear nucleus and to increase on
the contralateral side of experimental animals (Tucci et al., 2002).
In agreement with these studies, our results also demonstrate
decreased activity in the ipsilateral cochlear nucleus after UCHL.
In this regard, increases in auditory thresholds and decrease in
waves amplitudes in the ipsilateral side to the lesion were indica-
tive of reduced levels of cochlear inputs to auditory nuclei leading
to the suggestion that auditory circuitry is altered following uni-
lateral hearing loss. Supporting this idea, increases in the number
of cochlear nucleus neurons projecting ipsilaterally to the inferior
colliculus of the unmanipulated side (Nordeen et al., 1983; Moore
and Kitzes, 1985; Moore and Kowalchuk, 1988; Moore, 1994)
and increased calcium influx in deafferented auditory brainstem
nuclei that project to the inferior colliculus contralateral to the
lesion (Fuentes-Santamaria et al., 2003, 2005; Alvarado et al.,
2004) have been observed after experimental hearing loss in
gerbils and ferrets.
The magnitude of the effects of UCHL on synaptic trans-
mission varies depending on the species, the age of the animal
when hearing loss occurs and the lesion paradigm. In the cochlear
nucleus of adult guinea pigs, long-term plastic changes in GABA,
glycine and aspartate uptake and release take place after middle
ear ossicle removal (Potashner et al., 1997; Suneja et al., 1998).
Previous studies have demonstrated that short and long-term
alterations in receptor trafficking at synapses also occur in the
cochlear nucleus of adult rats following monoaural earplugging
(Whiting et al., 2009; Wang et al., 2011). Particularly by 1d after
unilateral hearing loss, GluA3 subunits of the AMPA receptor are
upregulated at auditory synapses on cochlear nucleus projection
neurons while glycine receptor α1 subunits are downregulated
at inhibitory synapses suggesting that decreased auditory nerve
activity compromises synaptic function.
Over the years, a number of studies have demonstrated that
glial cells play a pivotal role as regulators of synaptic stability
in response to brain damage (Bruce-Keller, 1999; Hanisch and
Kettenmann, 2007). Particularly in the cochlear nucleus, bilateral
cochlear ablation triggers a microglial activation process as early
as 16 h post-lesion. This response peaks at 24 h when the intracel-
lular levels of Iba1 are increased and microglial cells have adopted
a phenotype characterized by irregularly shaped hypertrophic
cell bodies with very few short processes (Fuentes-Santamaria
et al., 2012). The present findings indicate that reduced sound
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FIGURE 10 | Confocal images depicting the colocalization of NT-3
with the microglial marker CD11b in the ipsilateral cochlear
nucleus for each of the time points studied after the unilateral
ossicle removal in comparison to the contralateral side and
control animals. NT-3 immunostaining (blue) and cell nuclei stained
with DAPI (pseudo-colored red) are shown in A–F while CD11b
immunostained microglia (green) is illustrated in G–L. Appositions
between microglial cells (arrows) and NT-3 stained neurons (asterisks)
are indicated in M–R in control and experimental rats. Colocalizing
cellular elements are indicated by yellow arrowheads (S–Y) and cell
nuclei were stained with DAPI (blue). Scale bar = 20μm in F (also
applies to A–R); 20μm in Y (also applies to S–X).
transmission to the cochlea also triggers a microglial reaction in
the cochlear nucleus that is already present by 1d following the
lesion and reaches maximal levels by 4d post-lesion, a time point
at which activated microglia is seen in apposition to activity-
deprived auditory neurons. This functional relationship has also
been corroborated by electron microscopic observations demon-
strating that activated microglial processes are localized in the
neuropil contacting nearby cellular elements following the lesion.
These ultrastructural observations are in agreement with previous
studies suggesting that microglia-neuronal interactions are criti-
cal to regulate synaptic activity (Skibo et al., 2000; Shapiro et al.,
2009).
One of the mechanisms used by glial cells to facilitate the
exchange of cellular signals and restore synaptic homeostasis is
to increase the production and release of growth factors and
cytokines (Cullheim and Thams, 2007). In this regard, upreg-
ulation of IGF-1 and IL-1β levels in cochlear nucleus neurons
but not in glial cells has been observed in adult rats at 1, 7, and
15 d post-ablation suggesting that deprived auditory nucleus neu-
rons do not require additional IGF-1 and IL-1β synthesis by glial
cells to re-establish affected synaptic circuits (Fuentes-Santamaria
et al., 2007, 2013). Neurotrophins are also signaling molecules
expressed by neurons and microglia that serve trophic roles in
the normal brain (Elkabes et al., 1996; Zhang et al., 2007). In
agreement with our findings, NT-3 immunostaining in rats and
gerbils is localized within the cell body cytoplasm as well as in the
proximal dendrites and axon hillock of cochlear nucleus neurons
in the adult and developing brain (Burette et al., 1998; Hafidi,
1999; Tierney et al., 2001; Hossain et al., 2002). Interestingly,
recent findings in mice have provided evidence that NT-3 might
also be expressed in primary cochlear afferents which are inter-
mingled with the principal cells of the cochlear nucleus (Feng
et al., 2010, 2012). Feng et al. (2010), observed that NT-3 staining
was almost absent in the cytoplasm of cochlear nucleus neu-
rons, and hence, they hypothesized that NT-3 might be released
by supporting cells and inner hair cells in the inner ear, taken
by spiral ganglion neuron peripheral processes and transported
anterogradely to their endings in the cochlear nucleus. It is pos-
sible that the dissimilar findings between the study of Feng et al.
(2010) and the aforementioned studies in rats and gerbils together
with our observations might be due to species differences or to
the antibodies used by the different authors that might be rec-
ognizing different epitopes. Although in the current study we
have not evaluated whether NT-3 is also expressed in synaptic
endings from spiral ganglion neurons, we cannot rule out the pos-
sibility that the punctate staining observed in the neuropil and
surrounding cochlear nucleus neurons is presynaptic in nature.
Neurotrophic factors are activity-dependent molecular sig-
nals that play an important role in promoting auditory nerve
fiber growth and spiral ganglion neuron survival and in restor-
ing synaptic function and structure in response to hearing loss
(Suneja et al., 2005; Fukui et al., 2012). Increased neurotrophin
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FIGURE 11 | Confocal images depicting the colocalization of NT-3 with
the macroglial marker GFAP in the ipsilateral cochlear nucleus at 7d
post-lesion in comparison to the contralateral side and control animals.
NT-3 immunostaining (green) and cell nuclei stained with DAPI (blue) are
represented in A–C, while astroglial staining (red) is shown in D–F.
Colocalization of astrocytic processes with NT-3 is shown in G–I (yellow
arrows). Colocalyzing cellular elements in A–F are indicated by white arrows.
Scale bar = 20μm in I (also applies to A–H).
levels have been found in the adult cochlear nucleus of guinea pigs
at 7d after unilateral cochlear ablation and have been shown to
contribute to synaptogenesis following cochlear damage (Suneja
et al., 2005). Our results show that upregulation of neurotrophin
levels within neurons occurs at 4d following UCHL, a time point
at which the microglial response reached maximal levels. This
upregulation, together with the fact that microglial cells did not
increase NT-3 levels at any of the time points studied follow-
ing the lesion, indicates that transient increases in NT-3 likely
contributing to preservation of synaptic function in the cochlear
nucleus after UCHL, are part of activity-modulated neurotrophic
mechanisms involving cochlear neurons, but not microglial cells.
In this study we did not find evidence of astrocytes activation
at any of the time points included in this study. This suggests
that these glial cells may not contribute directly to neuronal
and synaptic adaptations to diminished activity in the cochlear
nucleus after conductive hearing loss. The ultrastructural fea-
tures of astrocytes described in this study are in agreement
with those presented under normal conditions in different brain
structures (Aoiki, 1992; Novikov et al., 2000). Astroglial reac-
tion has been described in the cochlear nucleus after uni- or
bilateral cochleotomy (Lurie and Rubel, 1994; De Waele et al.,
1996; Campos Torres et al., 1999; Insausti et al., 1999; Lurie and
Durham, 2000; Fredrich et al., 2013). In the adult rat, it reaches
maximal levels by 7d post-ablation when degeneration and reac-
tive synaptogenesis are in full progress. The fact that astrogliosis
seems to be more protracted and less persistent than microglial
activation has led to the hypothesis that differences in the tempo-
ral pattern of activation of both cell types may reflect cooperative
interactions to facilitate adult synaptogenesis following deafness
(Fuentes-Santamaria et al., 2013). The fact that we do not see an
astroglial reactive component, at least up to day 15 post-lesion,
may complement this hypothesis by providing evidence that per-
haps neuronal degeneration, like after cochleotomy, is required
to unleash an astroglial reaction, whereas microglial cells react
to adapt neurons and circuits to a broader range of lesion sit-
uations, ranging from attenuated activity to full-scale neuronal
degeneration. Finally, although previous studies have shown that
astrocytes might express NT-3 (Burette et al., 1998; Feng et al.,
2012), our observations indicate that only a small subpopulation
expresses this neurotrophin, both in control and experimental
animals. In summary, our results provide evidence that microglial
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cells, but not astrocytes, are involved in a transient response to
diminished activity in the cochlear nucleus, likely aimed at pre-
serving or adapting synaptic function. Although further studies
are still required, these findings suggest that modulation of the
microglial responses could be a pharmacological target of interest
for the treatment of pathologies that induce hearing loss.
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